Also listed on Ultrahuman Four Limited, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Aug 17, 2038 · High confidence
20-year base term ends Aug 17, 2038
Filed Aug 19, 2019 as application 16/543,884 · Granted Jun 16, 2020
Base term, 20 years from filing
Today
2018
2038
Clock starts
Aug 17, 2018
Aug 17, 2018
Term ends
Aug 17, 2038
Aug 17, 2038
Granted
Jun 16, 2020
Jun 16, 2020
base term
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Aug 17, 2018, when application PCT/GB2018/052347, the earliest non-provisional in its chain, was filed (this one was filed Aug 19, 2019) | Aug 17, 2038 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Aug 17, 2038 | High confidence |
This family
| US 10,683,350 | this patent Aug 2038 | Aug 2038 |
| US 11,370,840 | In force Mar 2039 | Mar 2039 |
| Application 17/849,101 | Abandoned not computed | not computed |
| Application 18/893,023 | Pending not computed | not computed |
4 of 5 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 21, 2019 Reel 50117, frame 304 | Finlay, William James Jonathan | Ultrahuman Four Limited | Assignment of Assignor's Interest |
| Oct 4, 2021 Reel 57710, frame 82 | Apcintex Limited; Janpix Limited; Capella Bioscience Ltd.; Lockbody Therapeutics Ltd.; Ultrahuman Two Limited; Ultrahuman Four Limited; Morphogen-IX Limited; Orexia Therapeutics Limited; Cardiokine Biopharma LLC; Palladio Biosciences, Inc.; Pearlriver Bio GmbH; Z Factor Limited | Cocoon S.A. LLC | Security Interest |
| Mar 2, 2022 Reel 59304, frame 38 | Ultrahuman Four Limited | Ultrahuman Four Limited | Change of Registered Office Address |
| Sep 28, 2023 Reel 65058, frame 96 | Ultrahuman Four Limited | Centessa Pharmaceuticals (UK) Limited | Assignment of Assignor's Interest |
| Dec 31, 2024 Reel 69708, frame 39 | Centessa Pharmaceuticals (UK) Limited | Oxford Finance LLC | Security Interest |
| Jun 12, 2026 Reel 75737, frame 1 | Cocoon S.A. LLC | Apcintex Limited; Janpix Limited; Capella Bioscience Ltd.; Lockbody Therapeutics Ltd.; Ultrahuman Two Limited; Ultrahuman Four Limited; Morphogen-IX Limited; Orexia Therapeutics Limited; Cardiokine Biopharma LLC; Centessa Biosciences, Inc.; Pearlriver Bio GmbH; Z Factor Limited | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Apcintex Limited | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Janpix Limited | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Capella Bioscience Ltd. | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Lockbody Therapeutics Ltd. | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Ultrahuman Two Limited | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Ultrahuman Four Limited | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Morphogen-IX Limited | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Orexia Therapeutics Limited | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Cardiokine Biopharma LLC | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Centessa Biosciences, Inc. | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Pearlriver Bio GmbH | Release of Security Interest |
| Jun 12, 2026 reel/frame not recorded | Cocoon S.A. LLC | Z Factor Limited | Release of Security Interest |
| Jun 24, 2026 Reel 75069, frame 879 | Oxford Finance LLC | Centessa Pharmaceuticals (UK) Limited | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Aug 2038
Term ends Aug 17, 2038. Maintenance fees still fall due before then
Citations
2
later US patents cite this one
That is below the median of utility patents granted in 2020 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.